LSD1/2-IN-4, a derivative of PCPA, functions as an inhibitor for both lysine-specific demethylase 1 (LSD1) and lysine-specific demethylase 2 (LSD2), demonstrating K i values of 0.11 µM and 130 µM against LSD1 and LSD2, respectively. This compound is utilized in researching various cancers, notably T-cell acute lymphoblastic leukemia (TALL) [1].
Molecular Weight:
248.07
Formula:
C9H8BrF2N
Target:
Histone Demethylase|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
